Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated: April 2, 2026, 3:30 am
Author: Getaka|Social: XLinkedIn

Phyto Chem (India) Ltd: Intrinsic Value & Share Price Analysis

Fair Value

₹22.34Fairly Valued by 3.43%vs CMP ₹21.60

P/E (15.0) × ROE (14.6%) × BV (₹12.50) × DY (2.00%)

Defaults: P/E=15

₹25.04Undervalued by 15.93%vs CMP ₹21.60
MoS: +13.7% (Thin)Confidence: 44/100 (Low)Models: 1 Under, 3 Over
ModelCategoryValueWeightSignal
PE-ROEEarnings₹14.8239%Over (-31.4%)
Net Asset ValueAssets₹12.4424%Over (-42.4%)
ROCE CapitalReturns₹68.4220%Under (+216.8%)
Revenue MultipleRevenue₹16.3318%Over (-24.4%)
Consensus (4 models)₹25.04100%Undervalued
Key Drivers: EPS CAGR -33.6% drags value — could be higher if earnings stabilize. | Wide model spread (₹12–₹68) — high uncertainty.

PE-ROE · Graham · EPV · DCF · NAV · EV/EBITDA · DDM · Earnings Yield · ROCE Capital · Revenue Multiple | CoE: 12% · Terminal: 4% · EPS CAGR: -33.6% · Defaults: P/E=15

*Investments are subject to market risks

Investment Snapshot

33
Phyto Chem (India) Ltd scores 33/100 (Weak)
Based on 5 dimensions: health, institutional flow, earnings quality, momentum, and peer comparison
Stock Health38/100 · Weak
ROCE 3.3% WeakROE 14.6% GoodD/E 1.89 High debtInterest Coverage 0.0x RiskyProfitable 3/5 years Mixed
Smart Money50/100 · Moderate
Promoter holding at 40.4% Stable
Earnings Quality30/100 · Weak
OPM contracting (8% → -16%) DecliningWorking capital: 130 days Capital intensive
Quarterly Momentum25/100 · Weak
Revenue (4Q): -21% YoY DecliningOPM: -8.4% (down 13.1% YoY) Margin pressure
Industry Rank30/100 · Weak
ROCE 3.3% vs industry 15.2% Below peers3Y sales CAGR: -15% Shrinking

Weights: Health 30% · Earnings Quality 25% · Momentum 20% · Industry Rank 15% · Smart Money 10%. Scores are computed from reported financials and recalculated daily. Not investment advice.

Share Price and Basic Stock Data

Last Updated: April 2, 2026, 3:30 am

Market Cap 9.31 Cr.
Current Price 21.6
Intrinsic Value₹25.04
High / Low 36.0/18.5
Stock P/E
Book Value 12.5
Dividend Yield0.00 %
ROCE3.27 %
ROE14.6 %
Face Value 10.0
PEG Ratio0.00

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for Phyto Chem (India) Ltd

Competitors

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
Epigral Ltd 3,749 Cr. 869 2,114/80611.1 4870.69 %24.9 %22.3 % 10.0
Dharmaj Crop Guard Ltd 803 Cr. 238 391/17516.6 1310.00 %12.0 %9.28 % 10.0
Bhaskar Agrochemicals Ltd 93.3 Cr. 179 200/56.614.4 40.00.56 %21.3 %24.7 % 10.0
Bhagiradha Chemicals & Industries Ltd 2,535 Cr. 196 331/170105 54.90.08 %7.44 %4.91 % 1.00
Best Agrolife Ltd 458 Cr. 12.9 35.8/12.318.9 22.81.55 %12.9 %9.95 % 1.00
Industry Average9,472.25 Cr1,009.7725.27369.000.53%15.21%19.87%6.67

All Competitor Stocks of Phyto Chem (India) Ltd

Quarterly Result

MetricDec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Sales 7.885.000.647.216.510.454.614.373.651.461.504.362.97
Expenses 7.604.361.916.675.763.745.633.813.482.512.024.803.22
Operating Profit 0.280.64-1.270.540.75-3.29-1.020.560.17-1.05-0.52-0.44-0.25
OPM % 3.55%12.80%-198.44%7.49%11.52%-731.11%-22.13%12.81%4.66%-71.92%-34.67%-10.09%-8.42%
Other Income 0.060.070.150.010.072.090.010.011.940.510.400.310.31
Interest 0.480.660.560.630.440.420.380.380.520.570.330.350.47
Depreciation 0.100.100.080.080.100.090.080.080.080.080.090.090.09
Profit before tax -0.24-0.05-1.76-0.160.28-1.71-1.470.111.51-1.19-0.54-0.57-0.50
Tax % 29.17%-360.00%0.00%0.00%0.00%0.00%-0.68%0.00%-0.66%-3.36%-9.26%-1.75%-2.00%
Net Profit -0.310.12-1.76-0.160.29-1.71-1.470.111.52-1.16-0.48-0.56-0.48
EPS in Rs -0.720.28-4.09-0.370.67-3.98-3.420.263.53-2.70-1.12-1.30-1.12

Last Updated: March 3, 2026, 3:43 pm

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: February 25, 2026, 10:46 am

MetricMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Sales 29.2940.9221.7744.4558.9059.1144.2244.4923.1226.7614.7514.0810.29
Expenses 26.3238.2720.2441.5856.7556.6842.3042.2821.7024.1618.0215.4212.55
Operating Profit 2.972.651.532.872.152.431.922.211.422.60-3.27-1.34-2.26
OPM % 10.14%6.48%7.03%6.46%3.65%4.11%4.34%4.97%6.14%9.72%-22.17%-9.52%-21.96%
Other Income -0.060.120.680.271.550.981.380.801.290.162.322.471.53
Interest 1.631.641.721.672.132.102.472.122.102.102.051.841.72
Depreciation 0.350.320.310.310.360.400.410.430.410.400.340.340.35
Profit before tax 0.930.810.181.161.210.910.420.460.200.26-3.34-1.05-2.80
Tax % 34.41%34.57%38.89%26.72%23.97%19.78%-4.76%-6.52%-15.00%15.38%-0.30%-5.71%
Net Profit 0.610.540.120.850.920.730.450.490.230.22-3.33-0.99-2.68
EPS in Rs 1.421.260.281.982.141.701.051.140.530.51-7.74-2.30-6.24
Dividend Payout % 70.49%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2014-20152015-20162016-20172017-20182018-20192019-20202020-20212021-20222022-20232023-20242024-2025
YoY Net Profit Growth (%)-11.48%-77.78%608.33%8.24%-20.65%-38.36%8.89%-53.06%-4.35%-1613.64%70.27%
Change in YoY Net Profit Growth (%)0.00%-66.30%686.11%-600.10%-28.89%-17.70%47.25%-61.95%48.71%-1609.29%1683.91%

Phyto Chem (India) Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.

Growth

Compounded Sales Growth
10 Years:-10%
5 Years:-20%
3 Years:-15%
TTM:-42%
Compounded Profit Growth
10 Years:%
5 Years:%
3 Years:%
TTM:100%
Stock Price CAGR
10 Years:-1%
5 Years:4%
3 Years:15%
1 Year:-5%
Return on Equity
10 Years:-1%
5 Years:-8%
3 Years:-16%
Last Year:-14%

Last Updated: September 5, 2025, 12:30 pm

Balance Sheet

Last Updated: December 4, 2025, 1:49 am

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital 4.304.304.304.304.304.304.304.304.304.304.304.304.30
Reserves 3.123.483.604.004.525.125.555.886.156.313.062.091.06
Borrowings 14.2216.0016.0418.4618.5522.0822.9821.3721.2319.4718.1915.7714.78
Other Liabilities 10.5311.925.6315.2430.3141.4634.8713.916.789.946.165.724.91
Total Liabilities 32.1735.7029.5742.0057.6872.9667.7045.4638.4640.0231.7127.8825.05
Fixed Assets 4.213.683.503.254.104.184.673.433.132.752.742.392.23
CWIP 0.000.000.000.000.090.450.000.000.000.000.000.000.00
Investments 0.320.320.320.240.250.120.110.160.170.070.080.050.07
Other Assets 27.6431.7025.7538.5153.2468.2162.9241.8735.1637.2028.8925.4422.75
Total Assets 32.1735.7029.5742.0057.6872.9667.7045.4638.4640.0231.7127.8825.05

Reserves and Borrowings Chart

Cash Flow

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Cash from Operating Activity + -1.71-2.13-0.341.530.761.951.49-0.713.411.423.411.77
Cash from Investing Activity + -0.710.320.600.160.240.26-0.391.060.050.21-0.051.02
Cash from Financing Activity + 2.431.79-0.48-1.76-1.02-2.19-1.10-0.40-3.45-1.70-3.26-2.91
Net Cash Flow 0.01-0.02-0.23-0.06-0.010.02-0.01-0.050.01-0.070.10-0.12
Free Cash Flow -2.44-2.17-0.481.46-0.541.111.040.443.301.443.151.79
CFO/OP -47%-70%-18%67%55%88%77%-33%238%56%-104%-137%

Free Cash Flow

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Free Cash Flow-11.25-13.35-14.51-15.59-16.40-19.65-21.06-19.16-19.81-16.87-21.46-17.11

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days 209.73155.83247.97212.84234.37306.89360.30182.87317.01275.66388.26369.41
Inventory Days 167.93159.73260.64133.35115.59128.58182.77172.49342.41314.83373.42338.21
Days Payable 99.24113.4386.08135.72176.25283.01338.07110.3241.10122.8791.0991.75
Cash Conversion Cycle 278.42202.12422.53210.47173.71152.46205.00245.04618.32467.62670.59615.87
Working Capital Days 59.3248.26103.9553.6243.7545.1469.5885.08155.35150.45161.34129.88
ROCE %13.06%12.02%7.75%11.16%12.34%10.16%8.98%6.96%7.28%7.55%-4.93%3.27%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Promoters 40.40%40.40%40.40%40.40%40.40%40.40%40.40%40.40%40.40%40.40%40.40%40.40%
DIIs 0.19%0.19%0.19%0.19%0.19%0.19%0.19%0.19%0.19%0.19%0.19%0.19%
Government 4.63%4.63%4.63%4.63%4.63%4.63%4.63%4.63%4.63%4.63%4.63%0.00%
Public 54.79%54.78%54.79%54.79%54.79%54.79%54.79%54.79%54.79%54.78%54.78%59.41%
No. of Shareholders 7,0937,0997,0667,0287,0317,1037,1987,2477,2137,2457,3037,354

Shareholding Pattern Chart

No. of Shareholders

Phyto Chem (India) Ltd: Intrinsic Value & Share Price Analysis - Shareholder trend analysis

This stock is not held by any mutual fund.

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 25Mar 24Mar 23Mar 22Mar 21
FaceValue 10.0010.0010.0010.0010.00
Basic EPS (Rs.) -2.31-7.750.520.531.15
Diluted EPS (Rs.) -2.31-7.750.520.531.15
Cash EPS (Rs.) -1.52-6.951.441.492.14
Book Value[Excl.RevalReserv]/Share (Rs.) 14.8517.1124.6824.3123.68
Book Value[Incl.RevalReserv]/Share (Rs.) 14.8517.1124.6824.3123.68
Revenue From Operations / Share (Rs.) 32.7434.4462.2353.76103.46
PBDIT / Share (Rs.) 2.62-2.206.426.287.00
PBIT / Share (Rs.) 1.84-3.005.505.336.01
PBT / Share (Rs.) -2.44-7.760.610.451.08
Net Profit / Share (Rs.) -2.31-7.750.510.531.15
PBDIT Margin (%) 8.01-6.3910.3111.686.76
PBIT Margin (%) 5.62-8.708.839.915.80
PBT Margin (%) -7.44-22.540.980.851.04
Net Profit Margin (%) -7.04-22.480.830.991.10
Return on Networth / Equity (%) -15.52-45.252.092.194.84
Return on Capital Employeed (%) 9.59-12.5916.0616.8317.57
Return On Assets (%) -3.55-10.500.550.601.09
Long Term Debt / Equity (X) 0.160.230.260.220.35
Total Debt / Equity (X) 2.472.471.831.881.89
Asset Turnover Ratio (%) 0.470.410.680.550.78
Current Ratio (X) 1.261.311.441.401.35
Quick Ratio (X) 0.740.750.850.880.81
Inventory Turnover Ratio (X) 1.281.111.310.942.24
Interest Coverage Ratio (X) 0.61-0.461.311.291.42
Interest Coverage Ratio (Post Tax) (X) 0.46-0.621.111.111.23
Enterprise Value (Cr.) 28.1831.7733.5128.1826.50
EV / Net Operating Revenue (X) 2.002.151.251.220.59
EV / EBITDA (X) 24.97-33.5412.1410.438.81
MarketCap / Net Operating Revenue (X) 0.880.920.520.370.16
Price / BV (X) 1.951.871.330.830.72
Price / Net Operating Revenue (X) 0.880.920.520.370.16
EarningsYield -0.07-0.240.010.020.06

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

About the Company - Qualitative Analysis

Phyto Chem (India) Ltd. is a Public Limited Listed company incorporated on 11/01/1989 and has its registered office in the State of Telangana, India. Company's Corporate Identification Number(CIN) is L24110TG1989PLC009500 and registration number is 009500. Currently Company is involved in the business activities of Manufacture of insecticides, rodenticides, fungicides, herbicides. Company's Total Operating Revenue is Rs. 14.08 Cr. and Equity Capital is Rs. 4.30 Cr. for the Year ended 31/03/2025.
INDUSTRYADDRESSCONTACT
Agro Chemicals/PesticidesSurvey No.628, Temple Street, Sangareddy Dist. Telangana 502313Contact not found
Management
NamePosition Held
Dr. P SreemannarayanaChairman
Mr. Y NayudammaManaging Director
Mr. Y Janaki RamaiahExecutive Director
Mr. S Y Sampath KumarIndependent Director
Dr. M Sreerama MurthyIndependent Director
Mrs. G VijithaIndependent Director
Mr. N Nagendra NaiduIndependent Director
Mr. N SudhakaAddnl.Non Exe.Independent Director
Mr. Y SreemannarayanaAddnl.Non Exe.Independent Director
Mr. K Srinivasa RaoAdditional Non Exe.Non Ind.Director

FAQ

What is the intrinsic value of Phyto Chem (India) Ltd and is it undervalued?

As of 11 April 2026, Phyto Chem (India) Ltd's intrinsic value is ₹25.04, which is 15.93% higher than the current market price of ₹21.60, suggesting the stock is undervalued. This is calculated using the PE ratio method factoring in ROE (14.6 %), book value (₹12.5), dividend yield (0.00 %), and 5-year EPS CAGR.

What is the current share price and 52-week range of Phyto Chem (India) Ltd?

Phyto Chem (India) Ltd is trading at ₹21.60 as of 11 April 2026, with a FY2026-2027 high of ₹36.0 and low of ₹18.5. The stock is currently near its 52-week low. Market cap stands at ₹9.31 Cr..

How does Phyto Chem (India) Ltd's P/E ratio compare to its industry?

Phyto Chem (India) Ltd has a P/E ratio of , which is below the industry average of 25.27. This is broadly in line with or below the industry average.

Is Phyto Chem (India) Ltd financially healthy?

Key indicators for Phyto Chem (India) Ltd: ROCE of 3.27 % is on the lower side compared to the industry average of 15.21%. Dividend yield is 0.00 %.

Is Phyto Chem (India) Ltd profitable and how is the profit trend?

Phyto Chem (India) Ltd reported a net profit of ₹-1 Cr in Mar 2025 on revenue of ₹14 Cr. Compared to ₹0 Cr in Mar 2022, the net profit shows a declining trend.

Does Phyto Chem (India) Ltd pay dividends?

Phyto Chem (India) Ltd has a dividend yield of 0.00 % at the current price of ₹21.60. The company is currently not paying meaningful dividends.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Phyto Chem (India) Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE
Explore Industry-wise Stock Analysis Reports